These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 34517454)

  • 41. [Relation between HBsAg levels during the immune clearance phase of hepatitis B virus infection and liver pathological stages of chronic hepatitis B].
    Zeng DW; Dong J; Chen LH; Zhu YY; Chen J; Zheng Q; Liu YR; Jiang JJ
    Zhonghua Gan Zang Bing Za Zhi; 2012 Oct; 20(10):746-50. PubMed ID: 23207334
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Diagnostic accuracy of transient elastography (FibroScan) versus the aspartate transaminase to platelet ratio index in assessing liver fibrosis in chronic hepatitis B: the role in primary care setting.
    Lesmana CR; Salim S; Hasan I; Sulaiman AS; Gani RA; Pakasi LS; Lesmana LA; Krisnuhoni E; Budihusodo U
    J Clin Pathol; 2011 Oct; 64(10):916-20. PubMed ID: 21670074
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation of APRI and FIB-4 scoring systems for non-invasive assessment of hepatic fibrosis in chronic hepatitis B patients.
    Kim WR; Berg T; Asselah T; Flisiak R; Fung S; Gordon SC; Janssen HL; Lampertico P; Lau D; Bornstein JD; Schall RE; Dinh P; Yee LJ; Martins EB; Lim SG; Loomba R; Petersen J; Buti M; Marcellin P
    J Hepatol; 2016 Apr; 64(4):773-80. PubMed ID: 26626497
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Application of heme oxygenase 1 in the diagnosis of non-alcoholic fatty liver disease].
    Yuan XW; Li DD; Liu LD; Zhang Y; Zhao W; Cui LY; Yang Y; Nan YM
    Zhonghua Gan Zang Bing Za Zhi; 2019 Apr; 27(4):291-297. PubMed ID: 31082341
    [No Abstract]   [Full Text] [Related]  

  • 45. Assessing liver fibrosis in chronic hepatitis B using MR extracellular volume measurements: Comparison with serum fibrosis indices.
    Wang HQ; Jin KP; Zeng MS; Chen CZ; Rao SX; Ji Y; Fu CX; Sheng RF
    Magn Reson Imaging; 2019 Jun; 59():39-45. PubMed ID: 30849483
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Clinical study on FibroTouch and multi-parameter model for diagnosis of hepatic fibrosis in patients with chronic liver disease].
    Wang R; Ren W; Zhao S; Niu X; Tan P; Du H; Nan Y
    Zhonghua Gan Zang Bing Za Zhi; 2015 Apr; 23(4):265-9. PubMed ID: 26133817
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The validity of serum markers for fibrosis staging in chronic hepatitis B and C.
    Li J; Gordon SC; Rupp LB; Zhang T; Boscarino JA; Vijayadeva V; Schmidt MA; Lu M;
    J Viral Hepat; 2014 Dec; 21(12):930-7. PubMed ID: 24472062
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A Novel Noninvasive Program for Staging Liver Fibrosis in Untreated Patients With Chronic Hepatitis B.
    Chen Y; Wang Y; Chen Y; Yu Z; Chi X; Hu KQ; Li Q; Tan L; Xiang D; Shang Q; Lei C; Chen L; Hu X; Wang J; Liu H; Lu W; Chi W; Dong Z; Wang X; Li Z; Xiao H; Chen D; Bai W; Zhang C; Xiao G; Qi X; Chen J; Zhou L; Sun H; Deng M; Qi X; Zhang Z; Qi X; Yang Y
    Clin Transl Gastroenterol; 2019 May; 10(5):1-12. PubMed ID: 31033506
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of elastography combined with serological indexes for hepatic fibrosis in patients with chronic hepatitis B.
    Xu B; Zhou NM; Cao WT; Li XJ
    World J Gastroenterol; 2018 Oct; 24(37):4272-4280. PubMed ID: 30310260
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of non-invasive assessment to diagnose liver fibrosis in chronic hepatitis B and C patients.
    Stibbe KJ; Verveer C; Francke J; Hansen BE; Zondervan PE; Kuipers EJ; de Knegt RJ; van Vuuren AJ
    Scand J Gastroenterol; 2011 Jul; 46(7-8):962-72. PubMed ID: 21623677
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical usefulness of mean platelet volume and red blood cell distribution width to platelet ratio for predicting the severity of hepatic fibrosis in chronic hepatitis B virus patients.
    Karagoz E; Ulcay A; Tanoglu A; Kara M; Turhan V; Erdem H; Oncul O; Gorenek L
    Eur J Gastroenterol Hepatol; 2014 Dec; 26(12):1320-4. PubMed ID: 25210777
    [TBL] [Abstract][Full Text] [Related]  

  • 52. APRI and FIB-4 are good predictors of the stage of liver fibrosis in chronic hepatitis B: the Chronic Hepatitis Cohort Study (CHeCS).
    Teshale E; Lu M; Rupp LB; Holmberg SD; Moorman AC; Spradling P; Vijayadeva V; Boscarino JA; Schmidt MA; Gordon SC;
    J Viral Hepat; 2014 Dec; 21(12):917-20. PubMed ID: 25131445
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Optimization of hepatitis B cirrhosis detection by stepwise application of transient elastography and routine biomarkers.
    Liang XE; Zhong C; Huang L; Yang S; Zhu Y; Chen Y; Hou J
    J Gastroenterol Hepatol; 2017 Feb; 32(2):459-465. PubMed ID: 27346683
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impact of age on the diagnostic performances and cut-offs of APRI and FIB-4 for significant fibrosis and cirrhosis in chronic hepatitis B.
    Li Q; Lu C; Li W; Huang Y; Chen L
    Oncotarget; 2017 Jul; 8(28):45768-45776. PubMed ID: 28514753
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Novel scores combining AFP with non-invasive markers for prediction of liver fibrosis in chronic hepatitis C patients.
    Gamil M; Alboraie M; El-Sayed M; Elsharkawy A; Asem N; Elbaz T; Mohey M; Abbas B; Mehrez M; Esmat G
    J Med Virol; 2018 Jun; 90(6):1080-1086. PubMed ID: 29315641
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A new combined predicting model using a non-invasive score for the assessment of liver fibrosis in patients presenting with chronic hepatitis B virus infection.
    Ben Ayed H; Koubaa M; Yaich S; Rekik K; Ben Jemaa T; Maaloul I; Marrekchi C; Damak J; Ben Jemaa M
    Med Mal Infect; 2019 Nov; 49(8):607-615. PubMed ID: 30871816
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Quantitative Measurement of Hepatic Fibrosis with Gadoxetic Acid-Enhanced Magnetic Resonance Imaging in Patients with Chronic Hepatitis B Infection: A Comparative Study on Aspartate Aminotransferase to Platelet Ratio Index and Fibrosis-4 Index.
    Lee GM; Kim YR; Ryu JH; Kim TH; Cho EY; Lee YH; Yoon KH
    Korean J Radiol; 2017; 18(3):444-451. PubMed ID: 28458596
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [A noninvasive model to predict histological liver cirrhosis in patients with chronic hepatitis B].
    Tu XL; Xiao YQ; Chen F
    Zhonghua Gan Zang Bing Za Zhi; 2009 Jan; 17(1):28-32. PubMed ID: 19203448
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Serum proteomic MRM identify peptide ions of transferrin as new fibrosis markers in chronic hepatitis B.
    Xu MY; Qu Y; Jia XF; Wang ML; Liu H; Wang XP; Zhang LJ; Lu LG
    Biomed Pharmacother; 2013 Sep; 67(7):561-7. PubMed ID: 23639231
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of liver inflammation on accuracy of FibroScan device in assessing liver fibrosis stage in patients with chronic hepatitis B virus infection.
    Huang LL; Yu XP; Li JL; Lin HM; Kang NL; Jiang JJ; Zhu YY; Liu YR; Zeng DW
    World J Gastroenterol; 2021 Feb; 27(7):641-653. PubMed ID: 33642834
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.